Cover Image
市場調查報告書

Advanced Cancer Therapeutics的產品平台分析

Advanced Cancer Therapeutics - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 226239
出版日期 內容資訊 英文 25 Pages
訂單完成後即時交付
價格
Back to Top
Advanced Cancer Therapeutics的產品平台分析 Advanced Cancer Therapeutics - Product Pipeline Review - 2015
出版日期: 2015年03月26日 內容資訊: 英文 25 Pages
簡介

Advanced Cancer Therapeutics是總公司在美國的生物科技企業。有膽鹼激酶和人類乳突病毒疫苗,與存在於多數癌症細胞表面的核仁素結合,促使細胞死亡的核酸適體等產品,開發白血病、前列腺癌症、腎癌症、乳癌等治療用途。

本報告提供Advanced Cancer Therapeutics 的治療藥開發平台的現狀及各開發階段比較分析、各藥物標靶、作用機制、給藥途徑、分子類型的治療藥的評估、最新的企業新聞和發表、後期階段及中止的計劃相關資訊等。

目錄

Advanced Cancer Therapeutics 基本資料

  • Advanced Cancer Therapeutics 概要
  • 主要資訊
  • 企業資料

Advanced Cancer Therapeutics :R&D概要

  • 主要的治療範圍

Advanced Cancer Therapeutics :開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品

Advanced Cancer Therapeutics :開發中產品概況

  • 在臨床階段的開發中產品
    • 第二階段的產品/聯合治療模式
    • 第一階段的產品/聯合治療模式
  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式

Advanced Cancer Therapeutics :藥物簡介

  • ACTGRO-777
  • PFK-158
  • CK-37
  • PFK-015
  • PU-27

Advanced Cancer Therapeutics :開發平台分析

  • 各標靶
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Advanced Cancer Therapeutics :最近的開發平台資訊

Advanced Cancer Therapeutics :開發休止的計劃

Advanced Cancer Therapeutics :總公司和子公司的所在地

  • 總公司

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC06897CDB

Summary

Global Markets Direct's, 'Advanced Cancer Therapeutics - Product Pipeline Review - 2015', provides an overview of the Advanced Cancer Therapeutics's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Advanced Cancer Therapeutics's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Advanced Cancer Therapeutics including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Advanced Cancer Therapeutics's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Advanced Cancer Therapeutics's pipeline products

Reasons to buy

  • Evaluate Advanced Cancer Therapeutics's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Advanced Cancer Therapeutics in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Advanced Cancer Therapeutics's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Advanced Cancer Therapeutics and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Advanced Cancer Therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Advanced Cancer Therapeutics and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Advanced Cancer Therapeutics Snapshot
    • Advanced Cancer Therapeutics Overview
    • Key Information
    • Key Facts
  • Advanced Cancer Therapeutics - Research and Development Overview
    • Key Therapeutic Areas
  • Advanced Cancer Therapeutics - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Advanced Cancer Therapeutics - Pipeline Products Glance
    • Advanced Cancer Therapeutics - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • Advanced Cancer Therapeutics - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Advanced Cancer Therapeutics - Drug Profiles
    • ACTGRO-777
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • PFK-158
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • CK-37
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • PFK-015
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • PU-27
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Advanced Cancer Therapeutics - Pipeline Analysis
    • Advanced Cancer Therapeutics - Pipeline Products by Target
    • Advanced Cancer Therapeutics - Pipeline Products by Molecule Type
    • Advanced Cancer Therapeutics - Pipeline Products by Mechanism of Action
  • Advanced Cancer Therapeutics - Recent Pipeline Updates
  • Advanced Cancer Therapeutics - Dormant Projects
  • Advanced Cancer Therapeutics - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Advanced Cancer Therapeutics, Key Information
  • Advanced Cancer Therapeutics, Key Facts
  • Advanced Cancer Therapeutics - Pipeline by Indication, 2015
  • Advanced Cancer Therapeutics - Pipeline by Stage of Development, 2015
  • Advanced Cancer Therapeutics - Monotherapy Products in Pipeline, 2015
  • Advanced Cancer Therapeutics - Phase II, 2015
  • Advanced Cancer Therapeutics - Phase I, 2015
  • Advanced Cancer Therapeutics - Preclinical, 2015
  • Advanced Cancer Therapeutics - Pipeline by Target, 2015
  • Advanced Cancer Therapeutics - Pipeline by Molecule Type, 2015
  • Advanced Cancer Therapeutics - Pipeline Products by Mechanism of Action, 2015
  • Advanced Cancer Therapeutics - Recent Pipeline Updates, 2015
  • Advanced Cancer Therapeutics - Dormant Developmental Projects,2015

List of Figures

  • Advanced Cancer Therapeutics - Pipeline by Top 10 Indication, 2015
  • Advanced Cancer Therapeutics - Pipeline by Stage of Development, 2015
  • Advanced Cancer Therapeutics - Monotherapy Products in Pipeline, 2015
  • Advanced Cancer Therapeutics - Pipeline by Top 10 Target, 2015
  • Advanced Cancer Therapeutics - Pipeline by Top 10 Molecule Type, 2015
  • Advanced Cancer Therapeutics - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top